MicroRNA-127 Inhibits the Progression of Melanoma by Downregulating Delta-Like Homologue 1

Table 1

Relationship between miR-127 level and clinicopathological characteristics.

Clinicopathological feature	Number	miR-127 level		value
		Low n (%)	High n (%)
Age				>0.05
<55 years	24	14 (58.3%)	10 (41.7%)
≥55 years	16	9 (56.3%)	7 (43.7%)
Gender				>0.05
Female	22	13 (59.1%)	9 (40.9%)
Male	18	10 (55.5%)	8 (44.5%)
Tumor thickness				<0.05
>10 mm	30	21 (70%)	9 (30%)
≤10 mm	10	2 (20%)	8 (80%)
Tumor stage				<0.05
I/II	14	6 (42.9%)	8 (57.1%)
III	26	17 (65.4%)	9 (34.6%)
Lymph node metastasis				>0.05
Yes	23	13 (56.5%)	10 (43.5%)
No	17	10 (58.8%)	7 (41.2%)